Cierra N. Sharp

Cierra N. Sharp

Jun 01, 2016

Group 6 Copy 61
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do birds carry Lyme disease?

    Although Lyme is considered to be endemic only in Europe and the northeastern and midwestern United States...

    What factors influence the spread of viruses through wild bee communities?

    We rely on bees to pollinate plants critical for our survival, but viruses threaten these key pollinators...

    The Secret Life of Parrots: decoding vocal babbling in wild parrot chicks

    I’m studying the first observable behavior of wild parrot babbling inside the nest. Similar to infants...

    Backer Badge Funded